Max Andersson

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(4):241-248
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [¹¹C]AZ10419369 Positron Emission Tomography Study
Tangen A; Veldman ER; Svensson J; Tiger M; Nord M; Sorjonen K; Andersson M; Plaven-Sigray P; Varrone A; Halldin C; Varnas K; Borg J; Lundberg J
Journal article: NEUROSCIENCE APPLIED. 2023;2:101035
Glutamate 5 receptor availability differences in twins discordant for autism and controls, do shared genetics matter
Griffioen G; Andersson M; Tangen Ä; Bolin M; Farde L; Halldin C; Bölte S; Lundberg J; Borg J
Article: MOLECULAR PSYCHIATRY. 2021;26(5):1647-1658
Serotonin transporter availability in adults with autism-a positron emission tomography study
Andersson M; Tangen A; Farde L; Bolte S; Halldin C; Borg J; Lundberg J
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(4):278-285
Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [¹⁸F]FMeNER-D₂
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Article: SCIENCE TRANSLATIONAL MEDICINE. 2018;10(461):eaam8434
GABA_A receptor availability is not altered in adults with autism spectrum disorder or in mouse models
Horder J; Andersson M; Mendez MA; Singh N; Tangen A; Lundberg J; Gee A; Halldin C; Veronese M; Bolte S; Farde L; Sementa T; Cash D; Higgins K; Spain D; Turkheimer F; Mick I; Selvaraj S; Nutt DJ; Lingford-Hughes A; Howes OD; Murphy DG; Borg J

Alla övriga publikationer

Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):169-170
Centrum semiovale as reference region - An evaluation of methods to quantify [18F]FPEB PET binding data in man
Andersson M; Varnas K; Halldin C; Borg J; Farde L; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S322-S323
Norepinephrine transporter occupancy of venlafaxine in patients with major depressive disorder using positron emission tomography and [18F]FMeNERD2
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Halldin C; Lundberg J
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2018;43:S133-S134
Quantification of Norepinephrine Transporter Occupancy of Venlafaxine Extended-Release in Patients With Major Depressive Disorder Using Positron Emission Tomography and Radioligand [18 F]FMeNER-D2
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asamin Y; Hirano Y; Halldin C; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S741-S742
Social cognition in autism spectrum disorder is associated with brain serotonin transporter availability
Tangen A; Andersson M; Nystrom K; Bolte S; Halldin C; Farde L; Lundberg J; Borg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S716-S717
A multicenter positron emission tomography study of GABA receptor availability in adults with autism
Andersson M; Horder J; Mendez M; Tangen A; Lundberg J; Gee A; Halldin C; Veronese M; Bolte S; Sementa T; Cash D; Turkheimer F; Mick S; Selvaraj S; Nutt D; Lingford-Hughes A; Howes O; Murphy D; Borg J
Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2017;58
Pilot results of a brain PET insert tested on a 3T MRI
Gonzalez A; Aguilar A; Gonzalez-Montoro A; Sanchez S; Sanchez F; Correcher C; Catret J; Yakushev I; Schweiger IS; Schwaiger M; Farde L; Andersson M; Aussenhofer S

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI